Abstract:Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide with limited therapeutic options. Comprehensive investigation of protein posttranslational modifications in HCC is still limited. Lysine acetylation is one of the most common types of posttranslational modification involved in many cellular processes and plays crucial roles in the regulation of cancer. In this study, we analyzed the proteome and K-acetylome in eight pairs of HCC tumors and normal adjacent tissues using a timsTOF Pro instrument. As a result, we identified 9219 K-acetylation sites in 2625 proteins, of which 1003 sites exhibited differential acetylation levels between tumors and normal adjacent tissues. Interestingly, many novel tumor-specific K-acetylation sites were characterized, for example, filamin A (K865), filamin B (K697), and cofilin (K19), suggesting altered activities of these cytoskeleton-modulating molecules, which may contribute to tumor metastasis. In addition, we observed an overall suppression of protein K-acetylation in HCC tumors, especially for enzymes from various metabolic pathways, for example, glycolysis, tricarboxylic acid cycle, and fatty acid metabolism. Moreover, the expression of deacetylase sirtuin 2 (SIRT2) was upregulated in HCC tumors, and its role of deacetylation in HCC cells was further explored by examining the impact of SIRT2 overexpression on the proteome and K-acetylome in Huh7 HCC cells. SIRT2 overexpression reduced K-acetylation of proteins involved in a wide range of cellular processes, including energy metabolism. Furthermore, cellular assays showed that overexpression of SIRT2 in HCC cells inhibited both glycolysis and oxidative phosphorylation. Taken together, our findings provide valuable information to better understand the roles of K-acetylation in HCC and to treat this disease by correcting the aberrant acetylation patterns.

Detection and quantification of lysine acetyl-alteration using antibody microarray.

Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic Workflow.

Lysine Acetylome Study Of Human Hepatocellular Carcinoma Tissues For Biomarkers And Therapeutic Targets Discovery

In-depth Profiling and Quantification of the Lysine Acetylome in Hepatocellular Carcinoma with a Trapped Ion Mobility Mass Spectrometer

Profiling of Lysine-Acetylated Proteins in Human Urine

New lysine-acetylated proteins screened by immunoaffinity and liquid chromatography-mass spectrometry

Site-Specific Acetyl Lysine Antibodies Reveal Differential Regulation of Histone Acetylation Upon Kinase Inhibition

Analysis of Lysine Acetylation and Acetylation-like Acylation In Vitro and In Vivo

Generation of Acetyllysine Antibodies and Affinity Enrichment of Acetylated Peptides

Lysine Acetylation, a More Prevalent Posttranslational Regulation of Protein Function

Prediction of Protein Lysine Acylation by Integrating Primary Sequence Information with Multiple Functional Features

Portable Detection of Lysine Acetyltransferase Activity in Lung Cancer Cells Based on a Miniature Electrochemical Sensor.

Position-Specific Analysis and Prediction for Protein Lysine Acetylation Based on Multiple Features

An Alternative Strategy for Pan-acetyl-lysine Antibody Generation

Characterization and Prediction of Lysine (K)-Acetyl-transferase Specific Acetylation Sites.

A Genetically Encoded F-19 Nmr Probe For Lysine Acetylation

Accurate in Silico Identification of Species-Specific Acetylation Sites by Integrating Protein Sequence-Derived and Functional Features.

Ac-LysargiNase Complements Trypsin for the Identification of Ubiquitinated Sites

An Mrm-Based Workflow For Absolute Quantitation Of Lysine-Acetylated Metabolic Enzymes In Mouse Liver

Immobilization of Antibodies on Magnetic Carbonaceous Microspheres for Selective Enrichment of Lysine‐acetylated Proteins and Peptides

Highly Sensitive Single-Molecule Counting Technology for Cytokeratin 18 Detection in Non-Alcoholic Fatty Liver Disease Using Novel Antibodies